Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer

by Kim Hyeong-Ryul, Nam Byung-Ho, Park Kang-Seo, Kim Hyun-Kyoung, Kim Dae-Seok, Jeong Jae-Heon, Choi Yong-Bock, Park Seong-Yeol, Jang Se-Jin, Choi Chang-Min, Kim Soo-Youl, Hong Kyeong-Man
Published 2011-09-01

Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)

by Kim Yu, Kim Jin, Min Yoo, HyunYoon Dok, Shin Ho-Jin, Mun Yeung-Chul, Park Yong, Do Young, Jeong Seong, Park Joon, Oh Sung, Lee Suee, Park Eun, Jang Joung-Soon, Lee Won-Sik, Lee Hwe-Won, Eom HyeonSeok, Ahn Jae-sook, Jeong Jae-Heon, Baek Sun, Kim Seok, Kim Won, Suh Cheolwon
Published 2012-08-01